Northwest Biotherapeutics reported 1.43M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US $ 13.73M 1.47M
Applied Genetic Technologies AGTC:US 667K 8K
Bristol Myers Squibb BMY:US $ 313M 13M
Cti Biopharma CTIC:US $ 3.97M 1.9M
Cytori Therapeutics CYTX:US $ 181K 17K
Infinity Pharmaceuticals INFI:US $ 0.04M 0M
Northwest Biotherapeutics NWBO:US 1.43M 471K
Pfizer PFE:US $ 293M 29M